The BioPharmaDispatch analysis of the recently released annual PBS Expenditure and Prescriptions report has confirmed the challenge of assessing the scheme based on spending growth but confirms how it has effectively transformed into two programs. …
Latest Video
New Stories
-
New national president for Hepatitis Australia
January 17, 2020 - - Latest News -
They would have already done it, if they could
January 17, 2020 - - Latest News -
New record for CSL as share prices tops $300
January 17, 2020 - - Latest News -
Leadership change coming for Novartis
January 16, 2020 - - Latest News -
Government moving to simplified non-legislated solution
January 16, 2020 - - Latest News -
Roche-Sarepta deal a positive sign for Australian access
January 16, 2020 - - Latest News -
PHARMAC wants more diabetes medicines, at the right price
January 16, 2020 - - Latest News